NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-239-2020-0-CA-01 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE CA National Stage 3216466 Pending
NIAID E-037-2021-1-CN-06 Antibodies Targeting The Spike Protein Of Coronaviruses CN National Stage 202280027556.2 Pending
NICHD E-210-2021-0-US-04 KITS AND METHODS FOR PREDICTION AND TREATMENT OF PREECLAMPSIA US CON 18/482,286 Pending
NINDS E-130-2022-3-EP-02 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE EP DIV 23202240.0 Pending
NCI E-237-2017-2-EA-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 EA DIV 202392526 Abandoned
NIAID E-047-2024-0-US-01 GENERATION OF ANTIGEN-SPECIFIC T AND B CELLS USING ENGINEERED COMMENSALS US 63/588,398 Expired
NCATS E-001-2023-1-PC-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF PCT PCT PCT/US2023/034438 Expired
NIAID E-239-2020-0-EP-01 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE EP National Stage 22724539.6 Pending
NCI E-225-2024-0-US-01 Novel autophagy modulating compounds and compositions and methods of treating neurodegenerative disease US 63/542,321 Expired
NCI E-118-2021-0-CA-01 Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors CA National Stage 3216228 Pending
NHLBI E-090-2020-1-US-01 NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE US CIP 18/480,306 Pending
NCI E-182-2017-0-SG-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION SG DIV 10202302822Q Pending
NCI E-171-2018-7-JP-01 MODIFIED CELLS AND METHODS OF THERAPY JP DIV 2023-171191 Pending
NCI E-166-2023-0-US-01 CANCER VACCINE AND METHOD OF USE THEREOF US 63/541,902 Abandoned
NCI E-253-2023-0-US-01 INTERFERON LAMBDA 4 AND USES THEREOF FOR TREATING HEPATIC INFLAMMATION AND LIVER DISEASE US 63/586,936 Expired
NEI E-155-2023-0-US-01 STIRRED BIOREACTOR SYSTEM US 63/541,656 Expired
NCI E-231-2023-0-US-01 COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELL-BASED VACCINES WITH ENHANCED EFFICACY US 63/586,629 Expired
NINDS E-181-2023-0-US-01 BRINCIDOFOVIR FOR TREATMENT OF DISEASES CAUSED BY B-CELLS INFECTED WITH EBV US 63/586,814 Expired
NHLBI E-223-2022-0-PC-01 Physiological Navigation In MRI Using Inherent Slab-selective Free-induction-decay Signal PCT PCT PCT/US2023/033997 Expired
NIDA E-208-2022-0-PCT-01 Dopamine D3/D2 Receptor Partial Agonists For The Treatment Of Neuropsychiatric Disorders PCT PCT PCT/US2023/033932 Expired
NHLBI E-160-2023-0-US-01 N-Lactoyl-Phenylalanine (Lac-Phe) compound derivatives US 63/585,791 Expired
NCI E-237-2017-1-SG-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION SG DIV 10202302739V Pending
NIDDK E-001-2022-0-US-02 MOTOR FOR A MR ELASTOGRAPHY TRANSDUCER US CON 18/474,332 1248-10-09 Issued PDF
NCATS E-039-2021-0-EP-01 METHODS AND SYSTEMS FOR SOLID PHASE EXTRACTION EP National Stage 22714325.2 Pending
NCI E-494-2013-0-AU-01 Methods of Preparing Anti-human Papillomavirus Antigen T Cells AU DIV 2023233209 Issued
NIAID E-060-2025-0-US-02 Immunogenic Compositions US National Stage 18/283,632 Pending
NIAID E-060-2025-1-US-02 Immunogenic Compositions US National Stage 18/283,516 Pending
CC E-241-2023-0-US-01 GAIT ASSISTANCE SYSTEMS AND METHODS OF CONTROL THEREOF US 63/539,898 Expired
NCI E-175-2016-0-AU-01 ANTI-KRAS-G12D T CELL RECEPTORS AU DIV 2023233125 Issued
NIAID E-212-2022-0-PC-01 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE PCT PCT PCT/US2023/074791 Expired
NIAID E-060-2025-1-EP-01 Immunogenic Compositions EP National Stage 22718633.5 Pending
NHLBI E-138-2023-0-US-01 A MOLECULAR SCAFFOLD FOR DEPLETING HRPN13 AND A SELECT GROUP OF KEN BOX PROTEINS US 63/539,663 Expired
NCI E-065-2021-0-CA-01 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS DESIGNED TO REDUCE RETROVIRAL RECOMBINATION AND USES THEREOF CA National Stage 3212978 Pending
NCATS E-244-2014-0-JP-02 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof JP DIV 2023-135162 Issued
NCI E-231-2017-0-US-02 IMMUNOTOXINS WITH ALBUMIN BINDING DOMAIN US DIV 18/471,137 12215164 Issued PDF
NCI E-028-2015-1-EP-01 Anti-Mutated Kras T Cell Receptors EP DIV 23198524.3 Pending
NCI E-065-2021-0-US-02 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS DESIGNED TO REDUCE RETROVIRAL RECOMBINATION AND USES THEREOF US National Stage 18/282,919 Pending
NHLBI E-087-2020-0-US-01 HERV-E ANTIBODIES AND METHODS OF THEIR USE US 63/539,170 Expired
NICHD E-058-2021-0-EP-01 La Protein As A Novel Regulator Of Osteoclastogenesis EP National Stage 22711784.3 Pending
NIAMS E-244-2020-0-EP-01 SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2 EP National Stage 22708683.2 Abandoned
NHLBI E-056-2021-0-CN-01 A New Molecular Scaffold For Targeting HRpn13 CN National Stage 202280022424.0 Abandoned
NCI E-111-2021-0-US-02 CANCER VACCINE AND METHOD OF USE THEREOF US National Stage 18/550,895 Pending
NIAID E-219-2023-0-US-01 STABILIZED SPIKE STEM-BASED PAN-BETACORONAVIRUS NANOPARTICLE VACCINES US 63/583,090 Expired
NIAID E-045-2021-0-EP-01 COMPOSITIONS OF MATTER COMPRISING STABILIZED CORONAVIRUS ANTIGENS AND THEIR USE EP National Stage 22709536.1 Pending
NIAID E-214-2021-2-KR-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides KR National Stage 10-2023-7031419 Pending
NCI E-029-2021-0-EP-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22 EP National Stage 22709092.5 Pending
NCATS E-039-2021-0-US-02 METHODS AND SYSTEMS FOR SOLID PHASE EXTRACTION US National Stage 18/550,239 Pending
NIAID E-214-2021-2-HK-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides HK EP 62024093381.7 Pending
NIAID E-214-2021-2-EP-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides EP National Stage 22756839.1 Pending
NCI E-237-2017-2-NZ-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 NZ DIV 803551 Pending